Henry J. Fuchs
EVP & Chief Medical Officer, Onyx Pharmaceuticals.
Companies
- BioMarin PharmaceuticalPresident Nov 29, 2016 to Sep 17, 20241
- Mirati Therapeutics, Inc.Board member Jul 12, 2013 to Jan 24, 20232
- Genomic HealthBoard member Sep 19, 2013 to Nov 14, 20193
- BioMarin PharmaceuticalChief Medical Officer Mar 4, 2009 to Aug 30, 20164
- Onyx PharmaceuticalsEVP & Chief Medical Officer Mar 3, 2006 to Nov 19, 20085
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
BioMarin Pharmaceutical BMRN185,074 shares6$10.1M at $54.75Sep 13, 2024- Mirati Therapeutics, Inc.10,465 shares7Jan 20, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Sep 13, 2024Shares withheld for tax 12,098 shares at $84.90 of BioMarin Pharmaceutical6
- Apr 30, 2024Granted 300 shares at $68.65 of BioMarin Pharmaceutical6
- Mar 15, 2024Shares withheld for tax 33,485 shares at $83.87 of BioMarin Pharmaceutical8
- Mar 15, 2024Granted 18,240 shares of BioMarin Pharmaceutical8
- Mar 5, 2024Sold 35,341 shares at $85.18 of BioMarin Pharmaceutical9
- Feb 27, 2024Granted 9,238 shares of BioMarin Pharmaceutical10
- Feb 27, 2024Granted 13,326 shares of BioMarin Pharmaceutical10
- Feb 27, 2024Granted 30,640 shares of BioMarin Pharmaceutical10
- Dec 1, 2023Granted 17,750 shares of BioMarin Pharmaceutical11
- Aug 10, 2023Sold 12,000 shares at $90.43 of BioMarin Pharmaceutical12
- Apr 28, 2023Granted 317 shares at $66.88 of BioMarin Pharmaceutical11
- Mar 16, 2023Shares withheld for tax 36,000 shares at $93.41 of BioMarin Pharmaceutical13
- Mar 15, 2023Shares withheld for tax 4,799 shares at $87.74 of BioMarin Pharmaceutical13
- Mar 15, 2023Granted 16,840 shares of BioMarin Pharmaceutical13
- Feb 28, 2023Granted 13,392 shares of BioMarin Pharmaceutical14
- Feb 28, 2023Granted 18,220 shares of BioMarin Pharmaceutical14
- Feb 28, 2023Granted 36,440 shares of BioMarin Pharmaceutical14
- Jan 20, 2023Granted 4,444 shares of Mirati Therapeutics, Inc.7
- Apr 29, 2022Granted 341 shares at $62.41 of BioMarin Pharmaceutical15
- Mar 16, 2022Shares withheld for tax 2,259 shares at $80.72 of BioMarin Pharmaceutical16
- Mar 15, 2022Shares withheld for tax 12,101 shares at $78.27 of BioMarin Pharmaceutical16
- Mar 15, 2022Granted 38,790 shares of BioMarin Pharmaceutical16
- Mar 8, 2022Granted 12,840 shares of BioMarin Pharmaceutical17
- Feb 11, 2022Sold 210 shares at $106.34 of Mirati Therapeutics, Inc.18
- Feb 11, 2022Sold 8,700 shares at $105.80 of Mirati Therapeutics, Inc.18
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARBioMarin Pharmaceutical, President
- 2
- 3SEC EDGARGenomic Health, Board member
- 4
- 5
- 6
- 7
- 8SEC EDGARForm 4 filed Mar 19, 2024
- 9SEC EDGARForm 4 filed Mar 7, 2024
- 10SEC EDGARForm 4 filed Feb 29, 2024
- 11SEC EDGARForm 4 filed Dec 5, 2023
- 12SEC EDGARForm 4 filed Aug 11, 2023
- 13SEC EDGARForm 4 filed Mar 17, 2023
- 14SEC EDGARForm 4 filed Mar 2, 2023
- 15SEC EDGARForm 5 filed Feb 10, 2023
- 16SEC EDGARForm 4 filed Mar 17, 2022
- 17SEC EDGARForm 4 filed Mar 10, 2022
- 18SEC EDGARForm 4 filed Feb 14, 2022